Form 4: ICU Medical Inc. Executive Daniel Woolson Reports Stock Transactions
SEC Form 4 Filing
Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc., reports the vesting and disposal of performance-based restricted stock units.
Summary
- On March 15, 2024, Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc., reported transactions involving common stock.
- Specifically, 2,923 performance-based restricted stock units (PRSUs) vested and were converted into common stock.
- Also on March 15, 2024, 1,294 shares of common stock were disposed of at a price of $98.08 per share.
- Following these transactions, Woolson directly owns 15,609 shares of ICU Medical Inc. common stock and 5,847 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of stock transactions (vesting of PRSUs and disposal of shares). |
| 03/15/2026 | Expiration date of Performance Shares. |
| 03/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.